Answers are grounded in this paper and cite their sources.
Background/objective: Hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) is rarely observed in patients without liver cirrhosis (LC).We evaluated the incidence and clinical feature of HCV-associated HCC patients with or without LC. Methods:The medical records of 1,516 patients diagnosed as having primary HCC at our hospital between January 2005 and December 2017 were retrospectively reviewed.Of these, 154 (10.2%)HCV-associated HCC patients were analyzed.LC was diagnosed histologically or clinically.Results: Seventeen (11.0%) of the 154 patients had non-cirrhotic HCC, and all were of Child-Turcotte-Pugh (CTP) class A, Among the 17 patients, 88.2% were male, all had nodular type HCC, and only 2 (11.8%) were under HCC surveillance.Median overall survival (OS) of HCVassociated HCC patients with and without LC was 15 months and 37 months, respectively.Cumulative OS rates were not different between non-cirrhotic patients and cirrhotic patients with CTP class A (P=0.229).Cumulative OS rates were significantly higher in non-cirrhotic patients than in cirrhotic patients of CTP class B (P<0.001) or C (P<0.001).Multivariate analyses showed serum AST (hazard ratio [HR] 1.01, P=0.003) and AFP levels (HR 1.01, P=0.016), antiviral therapy (HR 0.25, P=0.022), and LC of CTP class B (HR, 5.24, P=0.006) or C (HR 21.79, P<0.001) were significantly associated with prognosis in HCV-associated HCC patients.Conclusions: HCC in a non-cirrhotic liver was found in 11% of HCV-associated HCC patients.OSs of HCV-associated HCC patients were better in those of CTP A, regardless of LC than in those with LC of CTP class B or C. (J Liver Cancer 2021;21:34-44)
No takes yet. Share an insight, caveat, or question.
Shin et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: